Data / Form D filings / Skylark Bio, Inc.
Skylark Bio, Inc.: Form D filings
Skylark Bio, Inc., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on April 19, 2024, reports $40.9 million sold of a $40.9 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 325 VASSAR STREET, 2A, Cambridge, MA, 02139
- Phone
- (617) 526-6000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1942495
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Amendment | $40,889,315 | $40,889,315 | 2 | Aug 8, 2022 | sec.gov | |
| Aug 14, 2023 | Amendment | $34,889,315 | $22,889,315 | $12,000,000 | 2 | Aug 8, 2022 | sec.gov |
| Aug 16, 2022 | New notice | $34,889,315 | $22,889,315 | $12,000,000 | 2 | Aug 8, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steve A. Gillis | Director | |
| Giampiero A. De Luca | Director | |
| Jodi A. Cook | Executive Officer, Director | |
| Will A. McLean | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 15, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Skylark Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.